Product Information
MYCOPHENOLATE 200 MG/ML SUSP is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.9440 per ML under NDC 69238159502. Its NADAC has been published 213 times since Jun 29, 2022.
FDA first approved this application on Nov 2, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Mycophenolate Mofetil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/mL
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238159502
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MYCOPHENOLATE MOFETILApproval Type
Generic (ANDA)
FDA Application
ANDA214871FDA Approved
11/2/2021
TE Code
AB
On Market Since
11/5/2021
Pharmacological Classes
Price Statistics
The NADAC for MYCOPHENOLATE 200 MG/ML SUSP has been published 213 times since Jun 29, 2022, and over the history we have for it it has declined 82.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9440 per ML |
|---|---|
| All-time high | $5.2994 (Sep 14, 2022) |
| All-time low | $0.9324 (Jun 17, 2026) |
| 52-week high | $1.5140 |
| 52-week low | $0.9324 |
| Median price | $1.7286 |
| Average price | $2.1659 |
| Largest weekly change | -41.1% (Sep 21, 2022) |
| Weeks tracked | 213 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MYCOPHENOLATE 200 MG/ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for MYCOPHENOLATE 200 MG/ML SUSP, manufactured by Amneal Pharmaceuticals NY LLC, is $0.9440 per ML (NDC 69238159502), effective Aug 19, 2026.
How has the price of MYCOPHENOLATE 200 MG/ML SUSP changed over time?
Over the history we have for it, the NADAC for MYCOPHENOLATE 200 MG/ML SUSP has declined 82.2%. It has been tracked across 213 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for MYCOPHENOLATE 200 MG/ML SUSP?
Since Jun 29, 2022, the NADAC for MYCOPHENOLATE 200 MG/ML SUSP has ranged from a low of $0.9324 (Jun 17, 2026) to a high of $5.2994 (Sep 14, 2022), with a median of $1.7286 per ML.
Are there cheaper alternatives to MYCOPHENOLATE 200 MG/ML SUSP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MYCOPHENOLATE 200 MG/ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures MYCOPHENOLATE 200 MG/ML SUSP?
MYCOPHENOLATE 200 MG/ML SUSP (NDC 69238159502) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.